These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38033320)

  • 1. Physiologic Treatment of Severe Hypertension in Pregnancy and Postpartum.
    Davis AM; Blanchard CT; Subramaniam A; Sinkey RG; Tita AT; Battarbee AN
    Obstet Gynecol; 2024 Feb; 143(2):277-280. PubMed ID: 38033320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulse pressure as a predictor of response to treatment for severe hypertension in pregnancy.
    Mullan SJ; Vricella LK; Edwards AM; Powel JE; Ong SK; Li X; Tomlinson TM
    Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100455. PubMed ID: 34375751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postpartum Hypertension: Etiology, Diagnosis, and Management.
    Sharma KJ; Kilpatrick SJ
    Obstet Gynecol Surv; 2017 Apr; 72(4):248-252. PubMed ID: 28426127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials.
    Wu HZ; Cheng Y; Yu D; Li JB; Jiang YF; Zhu ZN
    Hypertens Pregnancy; 2022 May; 41(2):126-138. PubMed ID: 35361052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.
    Sridharan K; Sequeira RP
    Br J Clin Pharmacol; 2018 Sep; 84(9):1906-1916. PubMed ID: 29974489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.
    Firoz T; Magee LA; MacDonell K; Payne BA; Gordon R; Vidler M; von Dadelszen P;
    BJOG; 2014 Sep; 121(10):1210-8; discussion 1220. PubMed ID: 24832366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of factors associated with delayed treatment of obstetric hypertensive emergencies.
    Kantorowska A; Heiselman CJ; Halpern TA; Akerman MB; Elsayad A; Muscat JC; Sicuranza GB; Vintzileos AM; Heo HJ
    Am J Obstet Gynecol; 2020 Aug; 223(2):250.e1-250.e11. PubMed ID: 32067968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of nifedipine versus hydralazine in the management of severe hypertension in pregnancy: A randomised controlled trial.
    Adebayo JA; Nwafor JI; Lawani LO; Esike CO; Olaleye AA; Adiele NA
    Niger Postgrad Med J; 2020; 27(4):317-324. PubMed ID: 33154284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous labetalol versus oral nifedipine for acute hypertension in pregnancy: effects on cerebral perfusion pressure.
    Tolcher MC; Fox KA; Sangi-Haghpeykar H; Clark SL; Belfort MA
    Am J Obstet Gynecol; 2020 Sep; 223(3):441.e1-441.e8. PubMed ID: 32544404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of postpartum readmission after hypertensive disorder of pregnancy and variation by discharge antihypertensive medication prescription.
    Mitro SD; Hedderson M; Xu F; Forquer H; Baker JM; Kuzniewicz MW; Greenberg M
    Am J Obstet Gynecol; 2024 Oct; 231(4):456.e1-456.e13. PubMed ID: 38280432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Experiences of Intravenous Hydralazine and Labetalol for Acute Treatment of Severe Hypertension in Pregnant Thai Women.
    Chera-Aree P; Tengtrakulcharoen P; Leetheeragul J; Sampaojarean U; Surasereewong S; Wataganara T
    J Clin Pharmacol; 2020 Dec; 60(12):1662-1670. PubMed ID: 32598488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
    Easterling T; Mundle S; Bracken H; Parvekar S; Mool S; Magee LA; von Dadelszen P; Shochet T; Winikoff B
    Lancet; 2019 Sep; 394(10203):1011-1021. PubMed ID: 31378394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension.
    Hussein M; Mooij JM; Roujouleh H
    Kidney Blood Press Res; 2001; 24(2):124-8. PubMed ID: 11435745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial.
    Shekhar S; Sharma C; Thakur S; Verma S
    Obstet Gynecol; 2013 Nov; 122(5):1057-1063. PubMed ID: 24104790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing Intravenous Labetalol and Intravenous Hydralazine for Managing Severe Gestational Hypertension.
    Ehikioya E; Okobi OE; Beeko MAE; Abanga R; Abah NNI; Briggs L; Nwimo PN; Beeko PKA; Nwachukwu OB; Okoroafor CC
    Cureus; 2023 Jul; 15(7):e42332. PubMed ID: 37614273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with appropriate treatment of acute-onset severe obstetrical hypertension.
    Deshmukh US; Lundsberg LS; Culhane JF; Partridge C; Reddy UM; Merriam AA; Son M
    Am J Obstet Gynecol; 2021 Sep; 225(3):329.e1-329.e10. PubMed ID: 34023314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race/ethnicity differences in response to acute antihypertensive treatment of peripartum severe hypertension.
    Greene NH; Pon FF; Kilpatrick SJ
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):10103-10109. PubMed ID: 36042568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients.
    Gaynor MF; Wright GC; Vondracek S
    Ther Adv Cardiovasc Dis; 2018 Jan; 12(1):7-15. PubMed ID: 29265003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial.
    Vigil-De Gracia P; Ruiz E; López JC; de Jaramillo IA; Vega-Maleck JC; Pinzón J
    Hypertens Pregnancy; 2007; 26(2):163-71. PubMed ID: 17469006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of continuous infusion of nicardipine to control persistent postpartum hypertension: A retrospective study.
    Kim MK; Choe KR; Jeong DE; Lee KN; Cho I; Kim HJ; Park JY
    Medicine (Baltimore); 2022 Dec; 101(51):e32381. PubMed ID: 36595745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.